Target Price | $225.42 |
Price | $222.55 |
Potential | 1.29% |
Number of Estimates | 19 |
19 Analysts have issued a price target Cintas 2026 . The average Cintas target price is $225.42. This is 1.29% higher than the current stock price. The highest price target is $269.85 21.25% , the lowest is $164.63 26.03% . | |
A rating was issued by 27 analysts: 14 Analysts recommend Cintas to buy, 9 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Cintas stock has an average upside potential 2026 of 1.29% . Most analysts recommend the Cintas stock at Purchase. |
22 Analysts have issued a sales forecast Cintas 2026 . The average Cintas sales estimate is $11.3b . This is 9.62% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $11.8b 13.70% , the lowest is $10.8b 4.71% .
This results in the following potential growth metrics:
2025 | $10.3b | 7.75% |
---|---|---|
2026 | $11.3b | 9.62% |
2027 | $12.1b | 7.14% |
2028 | $13.0b | 7.30% |
2029 | $14.2b | 8.67% |
2030 | $15.2b | 7.61% |
2031 | $16.4b | 7.63% |
2032 | $17.7b | 7.63% |
21 Analysts have issued an Cintas EBITDA forecast 2026. The average Cintas EBITDA estimate is $3.2b . This is 10.37% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.4b 20.57% , the lowest is $2.7b 4.59% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $2.9b | 36.21% |
---|---|---|
2026 | $3.2b | 10.37% |
2027 | $3.4b | 8.89% |
2028 | $3.7b | 8.72% |
2029 | $4.1b | 9.95% |
2030 | $4.5b | 9.71% |
2031 | $4.9b | 9.65% |
2032 | $5.4b | 9.63% |
2025 | 27.60% | 26.42% |
---|---|---|
2026 | 27.79% | 0.69% |
2027 | 28.24% | 1.62% |
2028 | 28.62% | 1.35% |
2029 | 28.95% | 1.15% |
2030 | 29.52% | 1.97% |
2031 | 30.07% | 1.86% |
2032 | 30.63% | 1.86% |
22 Cintas Analysts have issued a net profit forecast 2026. The average Cintas net profit estimate is $2.0b . This is 10.15% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.1b 17.28% , the lowest is $1.9b 2.47% .
This results in the following potential growth metrics and future Net Margins:
2025 | $1.8b | 15.75% |
---|---|---|
2026 | $2.0b | 9.86% |
2027 | $2.2b | 9.70% |
2028 | $2.4b | 10.28% |
2029 | $2.7b | 10.75% |
2030 | $3.0b | 10.94% |
2031 | $3.3b | 10.69% |
2032 | $3.6b | 10.41% |
2025 | 17.53% | 7.43% |
---|---|---|
2026 | 17.56% | 0.19% |
2027 | 17.98% | 2.39% |
2028 | 18.48% | 2.78% |
2029 | 18.84% | 1.95% |
2030 | 19.42% | 3.08% |
2031 | 19.97% | 2.83% |
2032 | 20.49% | 2.60% |
22 Analysts have issued a Cintas forecast for earnings per share. The average Cintas EPS is $4.94 . This is 12.02% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.26 19.27% , the lowest is $4.60 4.31% .
This results in the following potential growth metrics and future valuations:
2025 | $4.42 | 16.62% |
---|---|---|
2026 | $4.94 | 11.76% |
2027 | $5.42 | 9.72% |
2028 | $5.98 | 10.33% |
2029 | $6.62 | 10.70% |
2030 | $7.34 | 10.88% |
2031 | $8.13 | 10.76% |
2032 | $8.98 | 10.46% |
Current | 50.60 | 0.74% |
---|---|---|
2026 | 45.16 | 10.74% |
2027 | 41.17 | 8.84% |
2028 | 37.33 | 9.33% |
2029 | 33.71 | 9.70% |
2030 | 30.38 | 9.88% |
2031 | 27.45 | 9.64% |
2032 | 24.86 | 9.44% |
Based on analysts' sales estimates for 2026, the Cintas stock is valued at an EV/Sales of 8.12 and an P/S ratio of 7.93 .
This results in the following potential growth metrics and future valuations:
Current | 8.90 | 8.27% |
---|---|---|
2026 | 8.12 | 8.73% |
2027 | 7.58 | 6.66% |
2028 | 7.07 | 6.80% |
2029 | 6.50 | 7.98% |
2030 | 6.04 | 7.07% |
2031 | 5.61 | 7.08% |
2032 | 5.22 | 7.09% |
Current | 8.70 | 8.77% |
---|---|---|
2026 | 7.93 | 8.78% |
2027 | 7.40 | 6.66% |
2028 | 6.90 | 6.80% |
2029 | 6.35 | 7.98% |
2030 | 5.90 | 7.07% |
2031 | 5.48 | 7.09% |
2032 | 5.09 | 7.09% |
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 18 2025 |
Baird |
Neutral
➜
Neutral
|
Unchanged | Jul 18 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Jul 18 2025 |
JP Morgan |
➜
Overweight
|
Unchanged | Jul 14 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Jul 02 2025 |
Wells Fargo |
Underweight
➜
Equal-Weight
|
Upgrade | Jul 01 2025 |
RBC Capital |
Sector Perform
➜
Sector Perform
|
Unchanged | Jun 09 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Jul 18 2025 |
Unchanged
Baird:
Neutral
➜
Neutral
|
Jul 18 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Jul 18 2025 |
Unchanged
JP Morgan:
➜
Overweight
|
Jul 14 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Jul 02 2025 |
Upgrade
Wells Fargo:
Underweight
➜
Equal-Weight
|
Jul 01 2025 |
Unchanged
RBC Capital:
Sector Perform
➜
Sector Perform
|
Jun 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.